Piperazine derivatives
US6844345B2 · kind B2 · utility
7Cited by
5References
41Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 7, 2002 |
| Grant date | Jan 18, 2005 |
| Priority date | — |
| Expiry date | Mar 7, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides piperazine derivatives in accordance with formula (I) as well as salts, hydrates and esters thereof. The substituent designations are as provided in the specification. The compounds of the present invention can be used in the treatment of type II diabetes or obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.